Diabetes
New Resource for Pharmacists and Patients
This new resource aims to provide critical information on injectable medications for the management of diabetes and obesity. The focus of this resource is to provide pharmacists a brief background on type 2 diabetes and obesity and education on key counseling points. This resource also contains pertinent patient education and can be downloaded and given to patients at the site of care.
Get Involved
The Diabetes Management Special Interest Group is a support network for pharmacists who share an interest in the area of diabetes management.
The Diabetes Management SIG will allow pharmacists in this area of practice to connect with others in the field and provide opportunities to discuss up-to-date disease management information.
Education and Training
APhA CPE programming related to diabetes management can be found in APhA's Learning Management System. Filter the course catalog by category and select diabetes management.
APhA CPE training programs and activities related to diabetes management include:
Practice Resources
- Focus on Interchangeable Biosimilar Insulins
This resource provides a summary for practicing pharmacists on recent developments of interchangeable biosimilar insulins in the treatment of diabetes. Information is included to prepare pharmacists to educate patients and answer questions about biosimilars and the availability of interchangeable biosimilar insulins.
- Focus on the Role of GLP-1 Receptor Agonists in the Management of Diabetes
This resource provides a summary for practicing pharmacists on pharmacologic approaches to the management of both type 1 and type 2 diabetes. The focus of this resource will be on the management of type 2 diabetes, with an emphasis on the use of glucagon-like peptide-1 (GLP-1) receptor agonists.
- Focus on Measures Beyond Hemoglobin A1c
This resource provides a summary for practicing pharmacists on recent developments in the treatment of diabetes. Key updates to recommendations for people with diabetes are highlighted and emerging information about the importance of time in range and glycemic variability are presented.
Diabetes Technology
- Practice Insights: Expanding Access to Continuous Glucose Monitoring (CGM) Technology in Community Pharmacies
Uptake of CGM technology has expanded in recent years, especially since Medicare began providing coverage for CGM devices in 2017. However, many important barriers to use remain. To explore how to utilize community pharmacists to expand patient access to CGM, the American Pharmacists Association (APhA) Foundation convened a virtual roundtable.
- Personal Continuous Monitoring (CGM) Playbook
The ADCES and APhA/APhA Foundation Personal CGM Implementation Playbook brings together information available from multiple sources to provide an inclusive and unbiased approach to implementation of Personal CGM into your practice. It includes a step-by-step approach to implementation, additional resources and the latest research.
Clinical Guidelines